Matches in SemOpenAlex for { <https://semopenalex.org/work/W2556228420> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W2556228420 abstract "Abstract Ex vivo T cell depletion (TCD) of the graft by CD34+ selection improves the tolerability of allogeneic hematopoietic stem cell transplantation (HCT). Clinical comorbidity measures enhance the estimates of HCT tolerance and outcomes. However, clinical prediction tools such as the hematopoietic cell transplantation-specific comorbidity index (HCT-CI) have not been validated in TCD transplants. To improve outcome prediction we therefore evaluated published comorbidity measures and other standard clinical biomarkers of outcome in a series of patients with hematological malignancies receiving myeloablative TCD transplants. Pre-transplant factors compared were: HCT-CI, European Group for Blood and Marrow Transplantation (EBMT) risk score, Eastern Cooperative Oncology Group (ECOG) Performance Status, serum C-reactive protein (CRP), albumin (ALB), pre-albumin (PAB), ferritin, absolute lymphocyte counts (ALC), and absolute lymphocyte / monocyte ratio (LMR). All patients received a myeloablative preparative regimen (Flu 125 mg/m2, Cytoxan 120mg/kg, TBI 400 cGy if older than 55 or 1200 cGy if younger than 55) followed by the infusion of a CD34+ selected graft from a HLA-identical sibling containing 1 to 5x10e4 CD3+/kg. Of the 79 recipients, 34 (43%) had standard risk disease, and 45 (57%) recipients had high-risk disease. At a median follow up of ~ 5 years, overall survival (OS) was 42.9% and nonrelapse mortality (NRM) was 32.9%. In the initial analyses we eliminated pre-transplant ECOG, ferritin, ALB, PAB, ALC and EBMT. The independent pre-transplant comorbidity variables identified for further testing were HCT-CI, CRP and LMR. We demonstrated that LMR and HCT-CI score are important independent clinical predictors of OS and NRM in TCD HCT. In univariate analysis of OS, significant factors were HCT-CI scores ≥ 5 (Hazard ratio (HR) 2.125, p= 0.018), CRP (HR=1.016, p=0.058, a trend) and LMR ≤ 1.3 (HR=2.054, p= 0.036). In multivariate models of OS, CRP (HR 1.02, p= 0.029), HCT-CI≥5 (HR 1.966, p= 0.04) and LMR ≤1.3 (HR 2.206, p= 0.029) retained significance. Further refinement of the multivariable model was made by classifying the LMR into a low-risk group (LMR 3-25) versus high-risk groups (LMR< 3 or > 25), then the significant factors were HCT-CI ≥5 (HR 3.008, p= 0.002), LMR < 3 (HR=3.292, p= 0.0014) and LMR > 25 (HR=5.648, p= 0.0008) compared to the LMR 3-25 group. In multivariable analysis of NRM, significant factors were HCT-CI ≥5 (HR 3.283, p= 0.015), LMR < 3 (HR=5.891, p= 0.0008), and LMR > 25 (HR=9.008, p= 0.0011) compared to the LMR 3-25 group. To evaluate the relevance of these factors in predicting the 5-year mortality and NRM beyond traditional risk indicators, we used the continuous net reclassification improvement (NRI) and the C-statistic (area under the receiver operating characteristic (ROC) curve). LMR was found to be the most important risk predictor for both OS and NRM (NRI was 84% and the C-statistic was improved from 0.59 to 0.68 with the addition of LMR to the multivariate model for OS; NRI was 108% and the C-statistic was improved from 0.57 to 0.72 with the addition of LMR to the multivariate model for NRM). Based on our results, we propose a simple novel predictive score for CD34+ selected myeloablative transplantation calculated by summation of scores derived from the HCT-CI [≤4 =Score 0, ≥5=Score 1] and LMR [3-25= Score 0, <3=Score 1, >25=Score 2]. The scores [range, 0 to 3] differentiate three risk groups for hematopoietic cell transplantation OS (p=0.001) and NRM (p=0.004). In conclusion, this is the first study to explore pre-transplant comorbidity measures after TCD HCT, identifying HCT-CI and LMR as critical predictors of OS and NRM. Figure 1 Figure 1. Disclosures No relevant conflicts of interest to declare." @default.
- W2556228420 created "2016-11-30" @default.
- W2556228420 creator A5003160211 @default.
- W2556228420 creator A5006736035 @default.
- W2556228420 creator A5016752979 @default.
- W2556228420 creator A5029569639 @default.
- W2556228420 creator A5051455016 @default.
- W2556228420 creator A5051959420 @default.
- W2556228420 creator A5058339214 @default.
- W2556228420 creator A5061303658 @default.
- W2556228420 creator A5074515375 @default.
- W2556228420 creator A5074922101 @default.
- W2556228420 creator A5079800586 @default.
- W2556228420 date "2014-12-06" @default.
- W2556228420 modified "2023-09-30" @default.
- W2556228420 title "Clinical Comorbidity Measures and Predictive Scores in Ex Vivo T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation" @default.
- W2556228420 doi "https://doi.org/10.1182/blood.v124.21.2550.2550" @default.
- W2556228420 hasPublicationYear "2014" @default.
- W2556228420 type Work @default.
- W2556228420 sameAs 2556228420 @default.
- W2556228420 citedByCount "0" @default.
- W2556228420 crossrefType "journal-article" @default.
- W2556228420 hasAuthorship W2556228420A5003160211 @default.
- W2556228420 hasAuthorship W2556228420A5006736035 @default.
- W2556228420 hasAuthorship W2556228420A5016752979 @default.
- W2556228420 hasAuthorship W2556228420A5029569639 @default.
- W2556228420 hasAuthorship W2556228420A5051455016 @default.
- W2556228420 hasAuthorship W2556228420A5051959420 @default.
- W2556228420 hasAuthorship W2556228420A5058339214 @default.
- W2556228420 hasAuthorship W2556228420A5061303658 @default.
- W2556228420 hasAuthorship W2556228420A5074515375 @default.
- W2556228420 hasAuthorship W2556228420A5074922101 @default.
- W2556228420 hasAuthorship W2556228420A5079800586 @default.
- W2556228420 hasConcept C126322002 @default.
- W2556228420 hasConcept C143998085 @default.
- W2556228420 hasConcept C203014093 @default.
- W2556228420 hasConcept C2777408962 @default.
- W2556228420 hasConcept C2779159551 @default.
- W2556228420 hasConcept C2911091166 @default.
- W2556228420 hasConcept C71924100 @default.
- W2556228420 hasConcept C90924648 @default.
- W2556228420 hasConceptScore W2556228420C126322002 @default.
- W2556228420 hasConceptScore W2556228420C143998085 @default.
- W2556228420 hasConceptScore W2556228420C203014093 @default.
- W2556228420 hasConceptScore W2556228420C2777408962 @default.
- W2556228420 hasConceptScore W2556228420C2779159551 @default.
- W2556228420 hasConceptScore W2556228420C2911091166 @default.
- W2556228420 hasConceptScore W2556228420C71924100 @default.
- W2556228420 hasConceptScore W2556228420C90924648 @default.
- W2556228420 hasLocation W25562284201 @default.
- W2556228420 hasOpenAccess W2556228420 @default.
- W2556228420 hasPrimaryLocation W25562284201 @default.
- W2556228420 hasRelatedWork W1964621323 @default.
- W2556228420 hasRelatedWork W2010222433 @default.
- W2556228420 hasRelatedWork W2462291502 @default.
- W2556228420 hasRelatedWork W2471675214 @default.
- W2556228420 hasRelatedWork W2532532282 @default.
- W2556228420 hasRelatedWork W2555588390 @default.
- W2556228420 hasRelatedWork W2558164335 @default.
- W2556228420 hasRelatedWork W2581877756 @default.
- W2556228420 hasRelatedWork W2584276898 @default.
- W2556228420 hasRelatedWork W2587071846 @default.
- W2556228420 hasRelatedWork W2591492208 @default.
- W2556228420 hasRelatedWork W2610423148 @default.
- W2556228420 hasRelatedWork W2912975411 @default.
- W2556228420 hasRelatedWork W2913573204 @default.
- W2556228420 hasRelatedWork W2921758834 @default.
- W2556228420 hasRelatedWork W2979442614 @default.
- W2556228420 hasRelatedWork W2979610397 @default.
- W2556228420 hasRelatedWork W3120860890 @default.
- W2556228420 hasRelatedWork W3197576875 @default.
- W2556228420 hasRelatedWork W2463938251 @default.
- W2556228420 isParatext "false" @default.
- W2556228420 isRetracted "false" @default.
- W2556228420 magId "2556228420" @default.
- W2556228420 workType "article" @default.